Related Experiment Video

Updated: Oct 6, 2026

Experimental Metastasis Assay
08:28

Experimental Metastasis Assay

Published on: August 24, 2010

Evidence for a role of Met-HGF/SF during Ras-mediated tumorigenesis/metastasis

C P Webb1, G A Taylor, M Jeffers

  • 1ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Maryland 21702, USA.

Oncogene
|November 3, 1998
PubMed

Insights

Ras oncogene transformation leads to Met receptor overexpression in cells, enhancing tumor growth and metastasis. This study reveals Met-hepatocyte growth factor/scatter factor signaling

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Aberrant Met-hepatocyte growth factor/scatter factor (HGF/SF) signaling is linked to cancer development and spread.
  • The Ras oncogene plays a critical role in cell transformation and tumorigenesis.

Purpose of the Study:

  • To investigate the role of Met-HGF/SF signaling in Ras-transformed cells.
  • To determine how Ras oncogene transformation affects Met receptor and HGF/SF expression and function.
  • To assess the impact of Met-HGF/SF signaling on tumor growth and metastasis in vivo.

Main Methods:

  • Utilized murine NIH3T3 and C127 cell lines transformed with the Ras oncogene.
  • Assessed Met receptor and HGF/SF expression levels in vitro and in vivo.
  • Evaluated HGF/SF-mediated cellular responses, including invasion through basement membrane.
  • Analyzed tumor growth in subcutaneous models and experimental lung metastasis.

Main Results:

  • Ras-transformed cells overexpressed the Met receptor, leading to enhanced HGF/SF responses and invasion in vitro.
  • While endogenous HGF/SF decreased in ras-transformed cells in vitro, tumors and metastases showed significantly higher levels of both Met and HGF/SF.
  • Met-HGF/SF signaling was found to promote tumor growth and metastasis in Ras-transformed cells.

Conclusions:

  • Met receptor overexpression and enhanced Met-HGF/SF signaling are key events in Ras-driven tumorigenesis and metastasis.
  • The complex regulation of HGF/SF expression in different tumor microenvironments influences metastatic potential.
  • Targeting Met-HGF/SF signaling may offer therapeutic strategies for Ras-mutated cancers.

More Related Videos

A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion06:36

A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion

Published on: April 24, 2015

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: